NDC 50268-549

Methenamine Hippurate

Methenamine Hippurate

Methenamine Hippurate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Methenamine Hippurate.

Product ID50268-549_b581d28f-810e-3733-e053-2a95a90a7d68
NDC50268-549
Product TypeHuman Prescription Drug
Proprietary NameMethenamine Hippurate
Generic NameMethenamine Hippurate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-12-02
Marketing CategoryANDA / ANDA
Application NumberANDA212172
Labeler NameAvPAK
Substance NameMETHENAMINE HIPPURATE
Active Ingredient Strength1000 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 50268-549-15

50 BLISTER PACK in 1 CARTON (50268-549-15) > 1 TABLET in 1 BLISTER PACK (50268-549-11)
Marketing Start Date2020-12-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Methenamine Hippurate" or generic name "Methenamine Hippurate"

NDCBrand NameGeneric Name
0115-1754Methenamine HippurateMethenamine Hippurate
0955-1037Methenamine HippurateMethenamine Hippurate
42571-332Methenamine HippurateMethenamine Hippurate
43199-020Methenamine HippurateMethenamine Hippurate
47781-577Methenamine HippurateMethenamine Hippurate
50268-549Methenamine HippurateMethenamine Hippurate
50742-142METHENAMINE HIPPURATEmethenamine hippurate
60687-694Methenamine HippurateMethenamine Hippurate
64720-139Methenamine HippurateMethenamine Hippurate
65862-782Methenamine HippurateMethenamine Hippurate
68151-0984Methenamine HippurateMethenamine Hippurate
69315-210Methenamine HippurateMethenamine Hippurate
30698-277HIPREXMethenamine Hippurate
30698-477HIPREXMethenamine Hippurate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.